
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Predicting complex kidney drug handling using a physiologically&#8208;based pharmacokinetic model informed by biomarker&#8208;estimated secretory clearance and blood flow - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F3920500002E8F19B7C50D.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="cts" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10766039/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766039/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Clinical and Translational Science" /><meta name="citation_title" content="Predicting complex kidney drug handling using a physiologically&#x02010;based pharmacokinetic model informed by biomarker&#x02010;estimated secretory clearance and blood flow" /><meta name="citation_author" content="Michael L. Granda" /><meta name="citation_author_institution" content="Division of Nephrology, Department of Medicine, University of Washington, Seattle Washington, USA" /><meta name="citation_author_institution" content="Kidney Research Institute, Seattle Washington, USA" /><meta name="citation_author" content="Weize Huang" /><meta name="citation_author_institution" content="Clinical Pharmacology, Genentech Inc., South San Francisco California, USA" /><meta name="citation_author_institution" content="Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle Washington, USA" /><meta name="citation_author" content="Catherine K. Yeung" /><meta name="citation_author_institution" content="Kidney Research Institute, Seattle Washington, USA" /><meta name="citation_author_institution" content="Department of Pharmacy, School of Pharmacy, University of Washington, Seattle Washington, USA" /><meta name="citation_author" content="Nina Isoherranen" /><meta name="citation_author_institution" content="Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle Washington, USA" /><meta name="citation_author" content="Bryan Kestenbaum" /><meta name="citation_author_institution" content="Division of Nephrology, Department of Medicine, University of Washington, Seattle Washington, USA" /><meta name="citation_author_institution" content="Kidney Research Institute, Seattle Washington, USA" /><meta name="citation_publication_date" content="2024/01" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="17" /><meta name="citation_doi" content="10.1111/cts.13678" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10766039/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10766039/" /><meta name="citation_pmid" content="37921258" /><meta name="DC.Title" content="Predicting complex kidney drug handling using a physiologically&#x02010;based pharmacokinetic model informed by biomarker&#x02010;estimated secretory clearance and blood flow" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Wiley" /><meta name="DC.Contributor" content="Michael L. Granda" /><meta name="DC.Contributor" content="Weize Huang" /><meta name="DC.Contributor" content="Catherine K. Yeung" /><meta name="DC.Contributor" content="Nina Isoherranen" /><meta name="DC.Contributor" content="Bryan Kestenbaum" /><meta name="DC.Date" content="2024 Jan" /><meta name="DC.Identifier" content="10.1111/cts.13678" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Predicting complex kidney drug handling using a physiologically&#x02010;based pharmacokinetic model informed by biomarker&#x02010;estimated secretory clearance and blood flow" /><meta property="og:type" content="article" /><meta property="og:description" content="Kidney function&#x02010;adjusted drug dosing is currently based solely on the estimated glomerular filtration rate (GFR), however, kidney drug handling is accomplished by a combination of filtration, tubular secretion, and re&#x02010;absorption. Mechanistic ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766039/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10766039/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2996/">Clin Transl Sci</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/452503/">v.17(1); 2024 Jan</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10766039
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10766039/pdf/CTS-17-e13678.pdf" class="int-view">PDF (863K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10766039/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10766039/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10766039" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10766039%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="JfP3GROViBTVcmeME87Xdpxj01xvKYculhcrFiQQTC3W7uqdyu2bkOcF59hNPheg">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10766039%2F&amp;text=Predicting%20complex%20kidney%20drug%20handling%20using%20a%20physiologically%02010based%20pharmacokinetic%20model%20informed%20by%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10766039%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766039/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10766039/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37921258/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10766039/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37921258/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10766039/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10766039/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2996/">Clin Transl Sci</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/452503/">v.17(1); 2024 Jan</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10766039
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-cts.gif" alt="Logo of cts" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Clin Transl Sci.</span> 2024 Jan; 17(1): e13678. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Nov 20. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1111%2Fcts.13678" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1111/cts.13678</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10766039</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37921258">37921258</a></div></div></div><h1 class="content-title">Predicting complex kidney drug handling using a physiologically&#x02010;based pharmacokinetic model informed by biomarker&#x02010;estimated secretory clearance and blood flow</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Granda%20ML%5BAuthor%5D" id="cts13678-cr-0001" class="affpopup" co-rid="_co_idm140404383642176" co-class="co-affbox">Michael L. Granda</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
1
,</sup><sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20W%5BAuthor%5D" id="cts13678-cr-0002" class="affpopup" co-rid="_co_idm140404383996608" co-class="co-affbox">Weize Huang</a>,<sup>
3
,</sup><sup>
4
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yeung%20CK%5BAuthor%5D" id="cts13678-cr-0003" class="affpopup" co-rid="_co_idm140404383992144" co-class="co-affbox">Catherine K. Yeung</a>,<sup>
2
,</sup><sup>
5
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Isoherranen%20N%5BAuthor%5D" id="cts13678-cr-0004" class="affpopup" co-rid="_co_idm140404383988416" co-class="co-affbox">Nina Isoherranen</a>,<sup>
4
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kestenbaum%20B%5BAuthor%5D" id="cts13678-cr-0005" class="affpopup" co-rid="_co_idm140404385775488" co-class="co-affbox">Bryan Kestenbaum</a><sup>
1
,</sup><sup>
2
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140404383642176"><h3 class="no_margin">Michael L. Granda</h3><p>
<sup>
1
</sup>
Division of Nephrology, Department of Medicine, 
University of Washington, 
Seattle
Washington, 
USA
</p><p>
<sup>
2
</sup>
Kidney Research Institute, 
Seattle
Washington, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Granda%20ML%5BAuthor%5D">Michael L. Granda</a></div></div><div id="_co_idm140404383996608"><h3 class="no_margin">Weize Huang</h3><p>
<sup>
3
</sup>
Clinical Pharmacology, 
Genentech Inc., 
South San Francisco
California, 
USA
</p><p>
<sup>
4
</sup>
Department of Pharmaceutics, School of Pharmacy, 
University of Washington, 
Seattle
Washington, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20W%5BAuthor%5D">Weize Huang</a></div></div><div id="_co_idm140404383992144"><h3 class="no_margin">Catherine K. Yeung</h3><p>
<sup>
2
</sup>
Kidney Research Institute, 
Seattle
Washington, 
USA
</p><p>
<sup>
5
</sup>
Department of Pharmacy, School of Pharmacy, 
University of Washington, 
Seattle
Washington, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yeung%20CK%5BAuthor%5D">Catherine K. Yeung</a></div></div><div id="_co_idm140404383988416"><h3 class="no_margin">Nina Isoherranen</h3><p>
<sup>
4
</sup>
Department of Pharmaceutics, School of Pharmacy, 
University of Washington, 
Seattle
Washington, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Isoherranen%20N%5BAuthor%5D">Nina Isoherranen</a></div></div><div id="_co_idm140404385775488"><h3 class="no_margin">Bryan Kestenbaum</h3><p>
<sup>
1
</sup>
Division of Nephrology, Department of Medicine, 
University of Washington, 
Seattle
Washington, 
USA
</p><p>
<sup>
2
</sup>
Kidney Research Institute, 
Seattle
Washington, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kestenbaum%20B%5BAuthor%5D">Bryan Kestenbaum</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140404378982384_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140404378982384_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140404378982384_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140404378982384_ai" style="display:none"><div class="fm-affl" id="cts13678-aff-0001">
<sup>
1
</sup>
Division of Nephrology, Department of Medicine, 
University of Washington, 
Seattle
Washington, 
USA
</div><div class="fm-affl" id="cts13678-aff-0002">
<sup>
2
</sup>
Kidney Research Institute, 
Seattle
Washington, 
USA
</div><div class="fm-affl" id="cts13678-aff-0003">
<sup>
3
</sup>
Clinical Pharmacology, 
Genentech Inc., 
South San Francisco
California, 
USA
</div><div class="fm-affl" id="cts13678-aff-0004">
<sup>
4
</sup>
Department of Pharmaceutics, School of Pharmacy, 
University of Washington, 
Seattle
Washington, 
USA
</div><div class="fm-affl" id="cts13678-aff-0005">
<sup>
5
</sup>
Department of Pharmacy, School of Pharmacy, 
University of Washington, 
Seattle
Washington, 
USA
</div><div><span class="fm-affl">Michael L. Granda, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@adnarglm" class="oemail">ude.wu@adnarglm</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="correspondenceTo"><sup>*</sup>

<strong>Correspondence</strong>
<br />
Michael L. Granda, Division of Nephrology, Harborview Medical Center, Kidney Research Institute, University of Washington, Box&#x000a0;359764, Seattle, WA 98104&#x02010;2499, USA.<br />
Email: <a href="mailto:dev@null" data-email="ude.wu@adnarglm" class="oemail">ude.wu@adnarglm</a>
<br />
</div></div><div class="fm-article-notes hide half_rhythm" id="idm140404378982384_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Jul 14; Revised 2023 Oct 4; Accepted 2023 Oct 23.</div></div><div class="permissions half_rhythm hide" id="idm140404378982384_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2023 The Authors. <em>Clinical and Translational Science</em> published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.</div><div class="license half_rhythm">This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
Appendix S1
</div><div><a href="/pmc/articles/PMC10766039/bin/CTS-17-e13678-s001.docx" data-ga-action="click_feat_suppl">CTS-17-e13678-s001.docx</a><span style="color:gray"> (220K)</span></div><div class="small guid">GUID: E6226C4E-7585-414B-8B93-B0819C823A87</div></div></dd></dl></div><div id="abstract-a.o.b.w" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.o.b.wtitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Kidney function&#x02010;adjusted drug dosing is currently based solely on the estimated glomerular filtration rate (GFR), however, kidney drug handling is accomplished by a combination of filtration, tubular secretion, and re&#x02010;absorption. Mechanistic physiologically&#x02010;based pharmacokinetic (PBPK) models recapitulate anatomic compartments to predict elimination from estimated perfusion, filtration, secretion, and re&#x02010;absorption, but clinical applications are limited by a lack of empiric individual&#x02010;level measurements of these functions. We adapted and validated a PBPK model to predict drug clearance from individual biomarker&#x02010;based estimates of kidney perfusion and secretory clearance. We estimated organic anion transporter&#x02010;mediated secretion via kynurenic acid clearance and kidney blood flow (KBF) via isovalerylglycine clearance in human participants, incorporating these measurements with GFR into the model to predict kidney drug clearance. We compared measured and model&#x02010;predicted clearances of administered tenofovir and oseltamivir, which are cleared by both filtration and secretion. There were 27 outpatients (age 55&#x02009;&#x000b1;&#x02009;15&#x02009;years, mean iohexol&#x02010;GFR [iGFR] 76&#x02009;&#x000b1;&#x02009;31&#x02009;mL/min/1.73&#x02009;m<sup>2</sup>) in this drug clearance study. The mean observed and mechanistic model&#x02010;predicted tenofovir clearances were 169&#x02009;&#x000b1;&#x02009;102&#x02009;mL/min and 163&#x02009;&#x000b1;&#x02009;80&#x02009;mL/min, respectively; estimated mean error of the mechanistic model was 37.1&#x02009;mL/min (95% confidence interval [CI]: 24&#x02013;52.9), compared to a mean error of 41.8&#x02009;mL/min (95% CI: 25&#x02013;61.6) from regression model. The mean observed and model&#x02010;predicted oseltamivir carboxylate clearances were 183&#x02009;&#x000b1;&#x02009;104&#x02009;mL/min and 179&#x02009;&#x000b1;&#x02009;89&#x02009;mL/min, respectively; estimated mean error of the mechanistic model was 42.9&#x02009;mL/min (95% CI: 29.7&#x02013;56.4), versus error of 48.1&#x02009;mL/min (95% CI: 31.2&#x02013;67.3) from the regression model. Individualized estimates of tubular secretion and KBF improved the accuracy of PBPK model&#x02010;predicted tenofovir and oseltamivir kidney clearances, suggesting the potential for biomarker&#x02010;informed measures of kidney function to refine personalized drug dosing.</p></div></div><div id="cts13678-body-0001" class="tsec sec"><h2 class="headless nomenu"></h2><p class="p p-first">
</p><div class="boxed-text-box whole_rhythm hide-overflow"><div class="caption"><h3 id="caption-a.p.a.a.atitle">Study Highlights</h3></div><p>
</p><ul class="simple" style="list-style-type:none" id="cts13678-list-0001"><li id="cts13678-li-0001"><div>
<strong>WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?</strong>
</div></li></ul><p>
</p><p>Kidney dosing of drugs clinically is based on estimated glomerular filtration rate (GFR) alone, despite the importance of proximal tubular secretion and reabsorption in determining drug clearance. Although typically linked, these functions may not decline proportionately to GFR. Physiologic&#x02010;based pharmacokinetic (PBPK) models can incorporate multiple elimination mechanisms in a population but are not responsive to individual variation in filtration versus secretion for clinical drug dosing.
</p><ul class="simple" style="list-style-type:none" id="cts13678-list-0002"><li id="cts13678-li-0002"><div>
<strong>WHAT QUESTION DID THIS STUDY ADDRESS?</strong>
</div></li></ul><p>
</p><p>Can clearance predictions be improved for drugs eliminated by both secretion and filtration using a previously validated PBPK model informed by individualized estimates of secretory clearance and kidney blood flow (KBF), in addition to GFR, compared to more standard linear models using GFR alone?
</p><ul class="simple" style="list-style-type:none" id="cts13678-list-0003"><li id="cts13678-li-0003"><div>
<strong>WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?</strong>
</div></li></ul><p>
</p><p>We show that drug clearance estimates of tenofovir and oseltamivir carboxylate are improved when utilizing the PBPK model trained on KBF and secretory clearance, in addition to measured GFR. We estimated KBF by measuring isovalerylglycine clearance, an endogenous solute with rapid elimination by filtration and secretion, and OAT&#x02010;mediated secretory clearance by measuring the clearance of kynurenic acid, an endogenous solute that is highly protein bound and eliminated by OAT1/3. This methodology was applied to 27 participants across a wide range of kidney function in a dedicated pharmacokinetic study.
</p><ul class="simple" style="list-style-type:none" id="cts13678-list-0004"><li id="cts13678-li-0004"><div>
<strong>HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?</strong>
</div></li></ul><p>
</p><p>These methods highlight the potential to better personalize drug dosing using individual biomarker&#x02010;based functional estimates of secretory clearance and KBF for drugs that have complex kidney handling.</p></div><p>
</p></div><div id="cts13678-sec-0003" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0003title">INTRODUCTION</h2><p class="p p-first">The kidneys eliminate hundreds of prescribed drugs and their metabolites from the circulation. Dose adjustment for kidney function represents standard clinical practice for achieving optimal drug exposure. Yet, prevailing methods for kidney dose&#x02010;adjustment do not account for the complex mechanisms of drug clearance. Specifically, kidney drug handling is determined by blood flow, plasma protein binding, glomerular filtration, tubular re&#x02010;absorption, and tubular secretion. In many cases, tubular secretory clearance represents the primary mechanism for eliminating protein bound drugs that are inefficiently filtered due to size/charge selectivity of the glomerular basement membrane. Tubular secretion is theoretically linked with glomerular filtration but this assumption is untested in real&#x02010;world settings and fails to account for individual&#x02010;level variation in renin&#x02010;angiotensin&#x02010;aldosterone activation, tubular transporter expression/function, and the underlying etiology of kidney disease.<sup><a href="#cts13678-bib-0001" rid="cts13678-bib-0001" class=" bibr popnode">
1
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0002" rid="cts13678-bib-0002" class=" bibr popnode">
2
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0003" rid="cts13678-bib-0003" class=" bibr popnode">
3
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0004" rid="cts13678-bib-0004" class=" bibr popnode">
4
</a></sup> Despite these considerations, clinical dose adjustments for decreased kidney function is currently based on only estimates of the glomerular filtration rate (eGFR), which are calculated from serum concentrations of creatinine and/or cystatin C.<sup><a href="#cts13678-bib-0005" rid="cts13678-bib-0005" class=" bibr popnode">
5
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0006" rid="cts13678-bib-0006" class=" bibr popnode">
6
</a></sup>
</p><p>Many drugs have mixed routes of elimination including both filtration and secretion, and individualized dosing tailored to the specific drug and patient is important in many clinical situations.<sup><a href="#cts13678-bib-0007" rid="cts13678-bib-0007" class=" bibr popnode">
7
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0008" rid="cts13678-bib-0008" class=" bibr popnode">
8
</a></sup> For instance, critically ill patients typically experience a complex milieu of malperfusion and subsequent multi&#x02010;organ failure, compounded by polypharmacy and a high likelihood of interactions as well as impaired metabolism and elimination; often, acute kidney injury can further catalyze nephrotoxicity from unadjusted dosing/overdosing.<sup><a href="#cts13678-bib-0009" rid="cts13678-bib-0009" class=" bibr popnode">
9
</a></sup> In addition, oncologic medications have narrow therapeutic indices with decades of established clinical practices seeking optimal adjusted dosing to avoid inadvertent toxicity. In both scenarios, there is also a morbid risk from lost efficacy in underdosing further highlighting a need for responsive and personalized adjustments.</p><p class="p p-last">Mechanistic physiologically&#x02010;based pharmacokinetic (PBPK) models capture multiple aspects of kidney drug clearance by dividing the kidney into separate compartments and modeling passage across vascular, cellular, and tubular spaces using physiological parameters and drug&#x02010;specific in&#x000a0;vitro data.<sup><a href="#cts13678-bib-0010" rid="cts13678-bib-0010" class=" bibr popnode">
10
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0011" rid="cts13678-bib-0011" class=" bibr popnode">
11
</a></sup> Mixed routes of drug elimination can be modeled using different functional parameters to permit more accurate dosing and facilitate the best clinical practice by predicting drug disposition, even in untested situations where formal pharmacokinetic data are not available.<sup><a href="#cts13678-bib-0010" rid="cts13678-bib-0010" class=" bibr popnode">
10
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0011" rid="cts13678-bib-0011" class=" bibr popnode">
11
</a></sup> PBPK models incorporate testable anatomic and biochemical determinants in its design therefore striving to align with the underlying physiologic process; however, remaining accurate for the single patient requires individual&#x02010;level functional and physiological information to separately capture filtration, re&#x02010;absorption, and tubular secretion to generate patient&#x02010;specific predictions in various clinical circumstances. Herein, we tested the feasibility of integrating individual, biomarker&#x02010;based estimates of kidney blood flow (KBF) and organic anion transporter (OAT)&#x02010;mediated tubular secretion for individualized predictions of kidney drug clearance. We estimated KBF and OAT&#x02010;mediated secretion in 27 participants from a kidney pharmacokinetic study via measured kidney clearance of isovalerylglycine and kynurenic acid (KA), respectively, and incorporated these with iohexol&#x02010;measured GFR into a mechanistic kidney PBPK model. We then compared measured and model&#x02010;predicted kidney clearances of administered tenofovir and oseltamivir carboxylate (the active metabolite of oseltamivir), which are cleared by both glomerular filtration and tubular secretion.<sup><a href="#cts13678-bib-0012" rid="cts13678-bib-0012" class=" bibr popnode">
12
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0013" rid="cts13678-bib-0013" class=" bibr popnode">
13
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0014" rid="cts13678-bib-0014" class=" bibr popnode">
14
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0015" rid="cts13678-bib-0015" class=" bibr popnode">
15
</a></sup>
</p></div><div id="cts13678-sec-0004" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0004title">METHODS</h2><div id="cts13678-sec-0005" class="sec sec-first"><h3 id="cts13678-sec-0005title">Study design</h3><p class="p p-first-last">This study was ancillary to the Proximal Tubular Clearance of Renal Medications (PROCLAIM) study, a pharmacokinetic study of kidney drug metabolism and excretion.<sup><a href="#cts13678-bib-0016" rid="cts13678-bib-0016" class=" bibr popnode">
16
</a></sup> Participants were recruited from 2017 to 2019 by medical record screening at the University of Washington (UW) hospital clinics. Recruitment was stratified by categories of normal and impaired kidney function based on eGFR. Patients were ineligible if possessing a history of nephrotic syndrome, cirrhosis, requiring renal replacement therapy, or actively using any of the study medications. A total of 54 participants completed the primary PROCLAIM study visit assessing furosemide and famciclovir clearance. All were invited to a secondary visit to investigate the pharmacokinetics of tenofovir and oseltamivir carboxylate; half completed the second visit, which is the subject of this investigation (Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0001/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0001" rid-ob="ob-cts13678-tbl-0001" co-legend-rid=""><span>1</span></a>). All participants provided voluntary informed consent and all study procedures were overseen by the UW Institutional Review Board.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="cts13678-tbl-0001"><h3>TABLE 1</h3><!--caption a7--><div class="caption"><p>Patient characteristics.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<em>N</em>&#x02009;=&#x02009;27<sup>
a
</sup>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="center" valign="top" rowspan="1" colspan="1">54 (15)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">17 (63%)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Race/ethnicity</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Black</td><td align="center" valign="top" rowspan="1" colspan="1">11 (41%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">White</td><td align="center" valign="top" rowspan="1" colspan="1">15 (56%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other/prefer not to answer</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">29.0 (5.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of diabetes</td><td align="center" valign="top" rowspan="1" colspan="1">3 (11%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">History of hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">4 (15%)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Relevant laboratory measurements</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">iGFR, mL/min/1.73&#x02009;m<sup>2</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">76 (30)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Kynurenic acid clearance, mL/min<sup>
b
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">226 (138)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Isovalerylglycine clearance, mL/min<sup>
b
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">575 (387)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Creatinine clearance, mL/min<sup>
b
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">105 (50)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Urine albumin, mg/24&#x02009;h<sup>
c
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">7.9 (3.5&#x02013;26)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Serum albumin, g/dL</td><td align="center" valign="top" rowspan="1" colspan="1">4.03 (0.24)</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Medications</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">RAAS inhibitor</td><td align="center" valign="top" rowspan="1" colspan="1">7 (26%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Thiazide diuretic</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3.7%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">K sparing diuretic</td><td align="center" valign="top" rowspan="1" colspan="1">2 (7.4%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Non&#x02010;steroid anti&#x02010;inflammatory</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3.7%)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Proton pump inhibitor</td><td align="center" valign="top" rowspan="1" colspan="1">3 (11%)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140404371573440"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/table/cts13678-tbl-0001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="cts13678-note-0002"><p class="p p-first-last">Abbreviations: iGFR, measured GFR based on renal clearance of iohexol; RAAS, renin&#x02010;angiotensin&#x02010;aldosterone system.</p></div><div id="cts13678-note-0003"><sup>
a
</sup>Mean (SD); <em>n</em> (%).</div><div id="cts13678-note-0004"><sup>
b
</sup>Derived from 10&#x02010;h urine collection and averaged plasma levels collected at 0, 60, 300, and 480&#x02009;min.</div><div id="cts13678-note-0005"><sup>
c
</sup>Median (interquartile range); standardized to 24&#x02009;h from supervised daytime urine collection.</div></div></div></div><div id="cts13678-sec-0006" class="sec"><h3 id="cts13678-sec-0006title">Drug clearance measurements</h3><p class="p p-first-last">Study personnel administered oral tenofovir alafenamide 50&#x02009;mg and oral oseltamivir 30&#x02009;mg, then collected 13 plasma samples (15, 30, 45, 60, 90, 120, 150, 180, 210, 240, 300, 480, and 600&#x02009;min) and a concurrent 10&#x02010;h timed urine collection after drug administration. Study drug concentrations of tenofovir and oseltamivir carboxylate, the active metabolite of oseltamivir, were quantified by liquid chromatography/tandem mass spectrometry analysis using validated assays.<sup><a href="#cts13678-bib-0016" rid="cts13678-bib-0016" class=" bibr popnode">
16
</a></sup> A standard noncompartmental analysis was conducted to determine pharmacokinetic parameters of each study drug. The area under the plasma concentration versus time curve (AUC) was calculated using the trapezoidal method. We calculated kidney clearance of each drug as:</p><div class="disp-formula" id="cts13678-disp-0001"><div class="f">
<math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="jats-math-1" display="block" overflow="scroll"><mrow><mrow><msub><mi>CL</mi><mtext>renal</mtext></msub><mo linebreak="goodbreak">=</mo><msup><mrow></mrow><mrow><mtext>Ae0</mtext><mo>&#x02192;</mo><mi>t</mi></mrow></msup><mo>/</mo><mtext>AUCplasma</mtext><mo>;</mo><mn>0</mn><mo>&#x02192;</mo><mi>t</mi></mrow></mrow></math>
</div></div><p>where Ae<sub>0&#x02009;&#x02192;&#x02009;<em>t</em>
</sub> represents the drug quantity recovered in the 10&#x02010;h urine sample and AUCplasma<sub>0&#x02009;&#x02192;&#x02009;<em>t</em>
</sub> represents the 10&#x02010;h plasma AUC.</p></div><div id="cts13678-sec-0007" class="sec"><h3 id="cts13678-sec-0007title">Secretory solute measurements</h3><p class="p p-first">We estimated effective KBF by the kidney clearance of isovalerylglycine, an endogenously produced solute, due to its rapid clearance (&#x0003e;4&#x02010;fold higher than GFR), low protein binding, and high extraction ratio. We estimated OAT&#x02010;mediated tubular secretory clearance by the kidney clearance of KA, an endogenously produced avid substrate of OAT1/3 that is highly (&#x0003e;90%) protein bound, limiting filtration.<sup><a href="#cts13678-bib-0017" rid="cts13678-bib-0017" class=" bibr popnode">
17
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0018" rid="cts13678-bib-0018" class=" bibr popnode">
18
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0019" rid="cts13678-bib-0019" class=" bibr popnode">
19
</a></sup> To increase the precision we measured plasma concentrations of isovalerylglycine and KA at 0, 60, 300, 480&#x02009;min, and in the supervised 10&#x02010;h urine collection, using our validated mass&#x02010;spectroscopic assay.<sup><a href="#cts13678-bib-0016" rid="cts13678-bib-0016" class=" bibr popnode">
16
</a></sup> Briefly, solvent&#x02010;precipitated plasma underwent solid&#x02010;phase extraction (Phree phospholipid removal plate; Phenomenex). Urine samples underwent two solid&#x02010;phase extractions (HLB &#x003bc;Elution plates; Waters). Dried extracts were reconstituted in acetonitrile/formic acid and passed through a large&#x02010;pore filter plate (MSBVN1210; Millipore). The resulting samples underwent liquid chromatography/tandem mass spectrometry (Shimadzu/Sciex 6500 q&#x02010;Trap) and quantification by internal/external standard curves.</p><p class="p p-last">The kidney clearance (CL<sub>R</sub>) of solutes were calculated as:</p><div class="disp-formula" id="cts13678-disp-0002"><div class="f">
<math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="jats-math-2" display="block" overflow="scroll"><mrow><mrow><msub><mi>CL</mi><mi>R</mi></msub><mo linebreak="goodbreak">=</mo><mfrac><mrow><msub><mi>U</mi><mi>x</mi></msub><mo>*</mo><mi>V</mi></mrow><mrow><mfrac><mn>1</mn><mi>n</mi></mfrac><mo>&#x02211;</mo><msub><mi>P</mi><mi>x</mi></msub></mrow></mfrac></mrow></mrow></math>
</div></div><p>where <em>U</em>
<sub>
<em>x</em>
</sub> represents the urinary solute concentration, <em>V</em> represents urine flow (mL/min), <em>n</em> is the number of plasma measurements, and <em>P</em>
<sub>
<em>x</em>
</sub> the time&#x02010;weighted plasma concentration. We measured GFR by plasma iohexol disappearance with concentrations measured by the University of Minnesota Research and Diagnostic Laboratory.<sup><a href="#cts13678-bib-0020" rid="cts13678-bib-0020" class=" bibr popnode">
20
</a></sup>
</p></div><div id="cts13678-sec-0008" class="sec"><h3 id="cts13678-sec-0008title">Mechanistic kidney model</h3><p class="p p-first">In this study, we leveraged our previously published physiologically&#x02010;based mechanistic kidney model to first estimate intrinsic secretory clearance via KA clearance, then to predict the kidney clearance of tenofovir and oseltamivir carboxylate for individual patients. Model equations and codes were previously provided.<sup><a href="#cts13678-bib-0010" rid="cts13678-bib-0010" class=" bibr popnode">
10
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0011" rid="cts13678-bib-0011" class=" bibr popnode">
11
</a></sup> This model consists of 35 compartments that resemble the physiology and anatomy of human kidneys, including glomerulus, peritubular blood vessels, renal tubular epithelial cells, tubules, and bladder. The vasculature, cells, and tubules are longitudinally divided into Bowman's capsule, proximal tubule, loop of Henle, distal tubule, and collecting duct. This allows the model to simulate drug concentration in different sections of the kidney at any timepoint following drug administration. To mechanistically describe kidney handling, the model includes unbound filtration, transporter&#x02010;mediated active secretion, and pH&#x02010;dependent passive re&#x02010;absorption. For patients with varying levels of kidney function (i.e., GFR), adaptive/compensatory physiological changes of tubular flow were incorporated, whereas other parameters, such as peritubular blood flow and tubular volume, all decreased proportionally with GFR.<sup><a href="#cts13678-bib-0010" rid="cts13678-bib-0010" class=" bibr popnode">
10
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0011" rid="cts13678-bib-0011" class=" bibr popnode">
11
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0021" rid="cts13678-bib-0021" class=" bibr popnode">
21
</a></sup> This mechanistic kidney model has been verified with clearance data of 46 drugs in healthy subjects and 20 compounds in subjects across a range of normal and abnormal GFRs.<sup><a href="#cts13678-bib-0010" rid="cts13678-bib-0010" class=" bibr popnode">
10
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0011" rid="cts13678-bib-0011" class=" bibr popnode">
11
</a></sup> In the present study, we incorporated individual&#x02010;level markers of KBF and proximal tubular secretory clearance into the model for each participant that was subsequently used for kidney drug clearance prediction as described below. This approach accounts for the intrinsic interindividual variability in kidney physiology and drug handling parameters and separates secretory and filtration mechanisms where they may not decline proportionally with GFR. The mechanistic kidney model structure and the modeling and simulation workflow is shown in Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0001" rid-ob="ob-cts13678-fig-0001" co-legend-rid="lgnd_cts13678-fig-0001"><span>1</span></a>. All parameter values for the biomarker and drugs used in the physiologically&#x02010;based mechanistic kidney model are summarized in Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0002/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0002" rid-ob="ob-cts13678-tbl-0002" co-legend-rid=""><span>2</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cts13678-fig-0001" co-legend-rid="lgnd_cts13678-fig-0001"><a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0001/" target="figure" rid-figpopup="cts13678-fig-0001" rid-ob="ob-cts13678-fig-0001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140404385252128"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is CTS-17-e13678-g003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is CTS-17-e13678-g003.jpg" src="/pmc/articles/PMC10766039/bin/CTS-17-e13678-g003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140404385252128"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/figure/cts13678-fig-0001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cts13678-fig-0001"><div><a class="figpopup" href="/pmc/articles/PMC10766039/figure/cts13678-fig-0001/" target="figure" rid-figpopup="cts13678-fig-0001" rid-ob="ob-cts13678-fig-0001">FIGURE 1</a></div><!--caption a7--><div class="caption"><p>Diagram of the mechanistic kidney model structure and the modeling and simulation workflow of leveraging individual measurement of CL<sub>r</sub> of isovalerylglycine, iohexol, and kynurenic acid to estimate intrinsic active secretion individually and to predict renal drug clearance for each subject. CL<sub>r</sub>, renal clearance; GFR, glomerular filtration rate; <em>i</em>, the number of subsegment each segment is divided into; OAT1/3, organic anion transporter 1/3; Q<sub>c</sub>, blood flow in the central compartment; Q<sub>kidney</sub>/Q<sub>k</sub>, blood flow to the kidney; Q<sub>urine</sub>, urine formation flow; single solid arrow, the fluid flow; single dash arrow, active secretion or active reabsorption; double arrow, bidirectional passive diffusion.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="cts13678-tbl-0002"><h3>TABLE 2</h3><!--caption a7--><div class="caption"><p>Parameter values for the biomarker and drugs in the physiologically&#x02010;based mechanistic kidney model.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Parameter</th><th align="left" valign="bottom" rowspan="1" colspan="1">Kynurenic acid</th><th align="left" valign="bottom" rowspan="1" colspan="1">Tenofovir</th><th align="left" valign="bottom" rowspan="1" colspan="1">Oseltamivir carboxylate</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Molecular weight, g/mol</td><td align="left" valign="top" rowspan="1" colspan="1">189.2</td><td align="center" valign="top" rowspan="1" colspan="1">287.2</td><td align="center" valign="top" rowspan="1" colspan="1">284.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LogP</td><td align="left" valign="top" rowspan="1" colspan="1">1.16</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.6</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Unbound fraction in plasma (<em>f</em>
<sub>u,p</sub>)</td><td align="left" valign="top" rowspan="1" colspan="1">0.07<sup>
a
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.993<sup>
b
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.97<sup>
c
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Blood&#x02010;to&#x02010;plasma ratio</td><td align="left" valign="top" rowspan="1" colspan="1">1<sup>
d
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.55<sup>
e
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.67<sup>
f
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Permeability (10<sup>&#x02212;6</sup>&#x02009;cm/s)</td><td align="left" valign="top" rowspan="1" colspan="1">1<sup>
d
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">0.37<sup>
e
</sup>
</td><td align="center" valign="top" rowspan="1" colspan="1">1.49<sup>
g
</sup>
</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140404367826304"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/table/cts13678-tbl-0002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="cts13678-note-0006"><sup>
a
</sup>Based on refs. [<sup><a href="#cts13678-bib-0017" rid="cts13678-bib-0017" class=" bibr popnode">17</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0022" rid="cts13678-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0023" rid="cts13678-bib-0023" class=" bibr popnode">23</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0024" rid="cts13678-bib-0024" class=" bibr popnode">24</a></sup>].</div><div id="cts13678-note-0007"><sup>
b
</sup>Based on ref. [<sup><a href="#cts13678-bib-0025" rid="cts13678-bib-0025" class=" bibr popnode">25</a></sup>].</div><div id="cts13678-note-0008"><sup>
c
</sup>Based on ref. [<sup><a href="#cts13678-bib-0026" rid="cts13678-bib-0026" class=" bibr popnode">26</a></sup>].</div><div id="cts13678-note-0009"><sup>
d
</sup>Assumed.</div><div id="cts13678-note-0010"><sup>
e
</sup>Based on ref. [<sup><a href="#cts13678-bib-0035" rid="cts13678-bib-0035" class=" bibr popnode">35</a></sup>].</div><div id="cts13678-note-0011"><sup>
f
</sup>Based on ref. [<sup><a href="#cts13678-bib-0036" rid="cts13678-bib-0036" class=" bibr popnode">36</a></sup>].</div><div id="cts13678-note-0012"><sup>
g
</sup>Based on ref. [<sup><a href="#cts13678-bib-0037" rid="cts13678-bib-0037" class=" bibr popnode">37</a></sup>].</div></div></div></div><div id="cts13678-sec-0009" class="sec"><h3 id="cts13678-sec-0009title">Estimation of individual intrinsic proximal tubular secretory clearance using kynurenic acid</h3><p class="p p-first">To estimate the OAT1/3&#x02010;mediated intrinsic secretion capacity, we used the iohexol&#x02010;GFR (iGFR) and kidney clearance of isovalerylglycine from each individual as model input values for GFR and KBF, respectively. We set the plasma unbound fraction of KA at 7% for all subjects, derived as the average from previous measurements in the literature of protein binding using different methodologies and also based on our finding that KA binding does not vary among patients with normal and impaired kidney function.<sup><a href="#cts13678-bib-0017" rid="cts13678-bib-0017" class=" bibr popnode">
17
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0022" rid="cts13678-bib-0022" class=" bibr popnode">
22
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0023" rid="cts13678-bib-0023" class=" bibr popnode">
23
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0024" rid="cts13678-bib-0024" class=" bibr popnode">
24
</a></sup>
</p><p class="p p-last">After inputting GFR and KBF to the model, we simulated KA clearance using the mechanistic model allowing for a range (10&#x02013;1000&#x02009;L/h) of secretory clearance values applied to both basolateral uptake and apical efflux clearance. We selected the model parameters from which the simulated intrinsic secretory clearance was numerically closest to the measured KA kidney clearance. We then quantified the degree of optimality (prediction/observation ratio) in which a ratio of 1 indicates an optimal prediction. The optimized unbound intrinsic secretion clearance of KA for each subject is summarized in Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0003/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0003" rid-ob="ob-cts13678-tbl-0003" co-legend-rid=""><span>3</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="cts13678-tbl-0003"><h3>TABLE 3</h3><!--caption a7--><div class="caption"><p>Measured CL<sub>r</sub> of iohexol, isovalerylglycine, and KA as the model inputs, and the model output of the optimized unbound intrinsic secretion clearance of KA for each subject.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">ID</th><th align="left" valign="bottom" rowspan="1" colspan="1">Iohexol CL<sub>r</sub> (mL/min)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Isovalerylglycine CL<sub>r</sub> (mL/min)</th><th align="left" valign="bottom" rowspan="1" colspan="1">KA CL<sub>r</sub> (mL/min)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Optimized unbound intrinsic secretion clearance (L/h)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">128</td><td align="center" valign="top" rowspan="1" colspan="1">1145</td><td align="center" valign="top" rowspan="1" colspan="1">313</td><td align="center" valign="top" rowspan="1" colspan="1">320</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">735</td><td align="center" valign="top" rowspan="1" colspan="1">288</td><td align="center" valign="top" rowspan="1" colspan="1">340</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">146</td><td align="center" valign="top" rowspan="1" colspan="1">1212</td><td align="center" valign="top" rowspan="1" colspan="1">409</td><td align="center" valign="top" rowspan="1" colspan="1">460</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">116</td><td align="center" valign="top" rowspan="1" colspan="1">468</td><td align="center" valign="top" rowspan="1" colspan="1">156</td><td align="center" valign="top" rowspan="1" colspan="1">160</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">134</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">292</td><td align="center" valign="top" rowspan="1" colspan="1">81</td><td align="center" valign="top" rowspan="1" colspan="1">85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">55</td><td align="center" valign="top" rowspan="1" colspan="1">237</td><td align="center" valign="top" rowspan="1" colspan="1">159</td><td align="center" valign="top" rowspan="1" colspan="1">280</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">63</td><td align="center" valign="top" rowspan="1" colspan="1">413</td><td align="center" valign="top" rowspan="1" colspan="1">150</td><td align="center" valign="top" rowspan="1" colspan="1">160</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">66</td><td align="center" valign="top" rowspan="1" colspan="1">551</td><td align="center" valign="top" rowspan="1" colspan="1">157</td><td align="center" valign="top" rowspan="1" colspan="1">160</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">369</td><td align="center" valign="top" rowspan="1" colspan="1">99</td><td align="center" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">139</td><td align="center" valign="top" rowspan="1" colspan="1">315</td><td align="center" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">180</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">110</td><td align="center" valign="top" rowspan="1" colspan="1">416</td><td align="center" valign="top" rowspan="1" colspan="1">195</td><td align="center" valign="top" rowspan="1" colspan="1">240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">134</td><td align="center" valign="top" rowspan="1" colspan="1">1692</td><td align="center" valign="top" rowspan="1" colspan="1">386</td><td align="center" valign="top" rowspan="1" colspan="1">380</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">95</td><td align="center" valign="top" rowspan="1" colspan="1">746</td><td align="center" valign="top" rowspan="1" colspan="1">211</td><td align="center" valign="top" rowspan="1" colspan="1">220</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">84</td><td align="center" valign="top" rowspan="1" colspan="1">567</td><td align="center" valign="top" rowspan="1" colspan="1">199</td><td align="center" valign="top" rowspan="1" colspan="1">220</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">110</td><td align="center" valign="top" rowspan="1" colspan="1">359</td><td align="center" valign="top" rowspan="1" colspan="1">174</td><td align="center" valign="top" rowspan="1" colspan="1">220</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">123</td><td align="center" valign="top" rowspan="1" colspan="1">667</td><td align="center" valign="top" rowspan="1" colspan="1">203</td><td align="center" valign="top" rowspan="1" colspan="1">220</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">96</td><td align="center" valign="top" rowspan="1" colspan="1">639</td><td align="center" valign="top" rowspan="1" colspan="1">249</td><td align="center" valign="top" rowspan="1" colspan="1">280</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">98</td><td align="center" valign="top" rowspan="1" colspan="1">912</td><td align="center" valign="top" rowspan="1" colspan="1">235</td><td align="center" valign="top" rowspan="1" colspan="1">240</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">91</td><td align="center" valign="top" rowspan="1" colspan="1">496</td><td align="center" valign="top" rowspan="1" colspan="1">164</td><td align="center" valign="top" rowspan="1" colspan="1">180</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">74</td><td align="center" valign="top" rowspan="1" colspan="1">192</td><td align="center" valign="top" rowspan="1" colspan="1">202</td><td align="center" valign="top" rowspan="1" colspan="1">1000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">111</td><td align="center" valign="top" rowspan="1" colspan="1">493</td><td align="center" valign="top" rowspan="1" colspan="1">501</td><td align="center" valign="top" rowspan="1" colspan="1">1000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">138</td><td align="center" valign="top" rowspan="1" colspan="1">1327</td><td align="center" valign="top" rowspan="1" colspan="1">565</td><td align="center" valign="top" rowspan="1" colspan="1">700</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">416</td><td align="center" valign="top" rowspan="1" colspan="1">398</td><td align="center" valign="top" rowspan="1" colspan="1">1000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">54</td><td align="center" valign="top" rowspan="1" colspan="1">533</td><td align="center" valign="top" rowspan="1" colspan="1">296</td><td align="center" valign="top" rowspan="1" colspan="1">420</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">76</td><td align="center" valign="top" rowspan="1" colspan="1">53</td><td align="center" valign="top" rowspan="1" colspan="1">95</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">161</td><td align="center" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">55</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140404367725200"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/table/cts13678-tbl-0003/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="cts13678-note-0013"><p class="p p-first-last">Abbreviations: CL<sub>r</sub>, renal clearance; KA, kynurenic acid.</p></div></div></div></div><div id="cts13678-sec-0010" class="sec"><h3 id="cts13678-sec-0010title">Mechanistic prediction of kidney clearance of tenofovir and oseltamivir</h3><p class="p p-first-last">We used iGFR and KBF from each individual as above as model input values to predict kidney clearance of tenofovir and oseltamivir carboxylate for each participant. The plasma unbound fractions of tenofovir and oseltamivir carboxylate were set as 99.3%<sup><a href="#cts13678-bib-0025" rid="cts13678-bib-0025" class=" bibr popnode">
25
</a></sup> and 97%<sup><a href="#cts13678-bib-0026" rid="cts13678-bib-0026" class=" bibr popnode">
26
</a></sup> for all subjects based on literature, and the estimated clearance of tenofovir and oseltamivir carboxylate in each participant was scaled based on the estimated intrinsic secretory clearance of KA as described above. Scalars were necessary to translate biomarker&#x02010;derived secretory clearance to a specific drug, which accounts for differences in substrate&#x02010;specific transporter maximum velocity and affinity (i.e., <em>K</em>
<sub>d</sub> or <em>K</em>
<sub>m</sub>) between KA and study drugs. We calculated optimized scalars of 0.033 for tenofovir and 0.038 for oseltamivir carboxylate when comparing to observed clearance.</p></div><div id="cts13678-sec-0011" class="sec sec-last"><h3 id="cts13678-sec-0011title">Assessing prediction accuracy</h3><p class="p p-first-last">We assessed the mechanistic model by generating goodness&#x02010;of&#x02010;fit plots comparing the individual prediction with individual observation alongside adjusted <em>R</em>&#x02010;square and Pearson and Spearman <em>r</em>. We generated a linear regression empirical model, fitting iGFR to observed drug clearance, as a prevailing method for determining function&#x02010;adjusted kidney drug clearance without use of a mechanistic model. We calculated absolute prediction error for each individual by subtracting the observed kidney clearance from the predicted kidney clearance, as well as mean and average&#x02010;fold error. Given small sample sizes, which make point estimates of error unreliable, we used bootstrapping to estimate the 95% confidence interval of prediction errors.</p></div></div><div id="cts13678-sec-0012" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0012title">RESULTS</h2><div id="cts13678-sec-0013" class="sec sec-first"><h3 id="cts13678-sec-0013title">Patient characteristics</h3><p class="p p-first">The mean age of the 27 study participants was 54&#x02009;&#x000b1;&#x02009;15&#x02009;years, 63% were men, and 56% identified as White. The mean iGFR was 76&#x02009;&#x000b1;&#x02009;31&#x02009;mL/min/1.73&#x02009;m<sup>2</sup> with the following distribution: six patients (22%) had iGFR less than 45, four (15%) with iGFR 45&#x02013;60, nine (33%) with iGFR 60&#x02013;90, and eight (30%) with iGFR greater than 90. Median urinary albumin was 7.9&#x02009;mg/24&#x02009;h (interquartile range: 3.5&#x02013;26; Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0001/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0001" rid-ob="ob-cts13678-tbl-0001" co-legend-rid=""><span>1</span></a>).</p></div><div id="cts13678-sec-0014" class="sec"><h3 id="cts13678-sec-0014title">Fitting intrinsic secretory clearance with kynurenic acid clearance</h3><p class="p p-first">The intrinsic secretory clearance of KA was determined by fitting the mechanistic model using observed KA kidney clearance (Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0002" rid-ob="ob-cts13678-fig-0002" co-legend-rid="lgnd_cts13678-fig-0002"><span>2</span></a>, left panel). Predicted KA kidney clearance using the optimized intrinsic secretory clearance differed from the observed KA kidney clearance by less than 5% for all but three patients (Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0002/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0002" rid-ob="ob-cts13678-tbl-0002" co-legend-rid=""><span>2</span></a>, Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0003" rid-ob="ob-cts13678-fig-0003" co-legend-rid="lgnd_cts13678-fig-0003"><span>3</span></a>). In those participants (38, 41, and 45), the measured kidney clearance of KA was greater than KBF estimated from isovalerylglycine clearance. The model follows the physiologic principle that secretory clearance cannot exceed KBF, leading to spurious predictions when violated by these imperfect functional estimates. For instance, measured isovalerylglycine kidney clearance in participant 38 was 192&#x02009;mL/min, lower than the observed KA kidney clearance of 202&#x02009;mL/min. Hence, the maximum simulated kidney clearance of KA would asymptotically approach the measured kidney clearance of isovalerylglycine of 192&#x02009;mL/min as it represents the KBF but could not reach the observed kidney clearance of KA of 202&#x02009;mL/min as secretory clearance could not exceed KBF (Figure&#x000a0;<a href="#cts13678-supitem-0001" rid="cts13678-supitem-0001" class=" supplementary-material">S1B</a>). Therefore, the estimated unbound intrinsic secretory clearance of KA (Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0003/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0003" rid-ob="ob-cts13678-tbl-0003" co-legend-rid=""><span>3</span></a>) for the affected participants reached the predefined maximum of 1000&#x02009;L/h. The mechanistic reason for this phenomenon is unclear and warrants further investigation, one hypothesis is that, in the case of these three patients, KA is more efficiently extracted by the kidneys than isovalerylglycine which serves as the biomarker for renal blood flow. This may be due to differences in OAT1/OAT3 expression level of specific variants that transport KA and isovalerylglycine with different capacity and efficiency.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cts13678-fig-0002" co-legend-rid="lgnd_cts13678-fig-0002"><a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0002/" target="figure" rid-figpopup="cts13678-fig-0002" rid-ob="ob-cts13678-fig-0002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140404367829600"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is CTS-17-e13678-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is CTS-17-e13678-g001.jpg" src="/pmc/articles/PMC10766039/bin/CTS-17-e13678-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140404367829600"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/figure/cts13678-fig-0002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cts13678-fig-0002"><div><a class="figpopup" href="/pmc/articles/PMC10766039/figure/cts13678-fig-0002/" target="figure" rid-figpopup="cts13678-fig-0002" rid-ob="ob-cts13678-fig-0002">FIGURE 2</a></div><!--caption a7--><div class="caption"><p>Assessment of mechanistic kidney model in predicting tenofovir (TFV) renal clearance (CL<sub>r</sub>). Linear regression model (a, c, e) using CL<sub>r</sub> of iohexol (iGFR) alone is compared to the mechanistic kidney model (b, d, f) which incorporates iGFR, kidney blood flow (via isovalerylglycine clearance), and OAT&#x02010;mediated secretory clearance (via kynurenic acid clearance). Goodness&#x02010;of&#x02010;fit plots show the comparison between individual prediction of TFV CL<sub>r</sub> and individual observation of TFV CL<sub>r</sub>, with adjusted <em>R</em>&#x02010;square, Pearson <em>r</em>, and Spearman <em>&#x003c1;</em> displayed (a, b). Error plots show the individual absolute prediction error (c, d) and individual normalized prediction error (e, f) with mean error, average fold error, and absolute average fold error displayed. Blue circles represent individual data, red dashed lines represent twofold error, and red solid lines represent error&#x02010;free.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="cts13678-fig-0003" co-legend-rid="lgnd_cts13678-fig-0003"><a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0003/" target="figure" rid-figpopup="cts13678-fig-0003" rid-ob="ob-cts13678-fig-0003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140404367728960"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is CTS-17-e13678-g002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is CTS-17-e13678-g002.jpg" src="/pmc/articles/PMC10766039/bin/CTS-17-e13678-g002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140404367728960"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/figure/cts13678-fig-0003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_cts13678-fig-0003"><div><a class="figpopup" href="/pmc/articles/PMC10766039/figure/cts13678-fig-0003/" target="figure" rid-figpopup="cts13678-fig-0003" rid-ob="ob-cts13678-fig-0003">FIGURE 3</a></div><!--caption a7--><div class="caption"><p>Assessment of mechanistic kidney model in predicting oseltamivir carboxylate (OC) renal clearance (CL<sub>r</sub>). Linear regression model (a, c, e) using CL<sub>r</sub> of iohexol (iGFR) alone is compared to the mechanistic kidney model (b, d, f) which incorporates iGFR, kidney blood flow (via isovalerylglycine clearance), and OAT&#x02010;mediated secretory clearance (via kynurenic acid clearance). Goodness&#x02010;of&#x02010;fit plots show the comparison between individual prediction of TFV CL<sub>r</sub> and individual observation of TFV CL<sub>r</sub>, with adjusted <em>R</em>&#x02010;square, Pearson <em>r</em>, and Spearman <em>&#x003c1;</em> displayed (a, b). Error plots show the individual absolute prediction error (c, d) and individual normalized prediction error (e, f) with mean error, average fold error, and absolute average fold error displayed. Blue circles represent individual data, red dashed lines represent twofold error, and red solid lines represent error&#x02010;free.</p></div></div></div></div><div id="cts13678-sec-0015" class="sec sec-last"><h3 id="cts13678-sec-0015title">Drug clearance prediction using mechanistic kidney model</h3><div id="cts13678-sec-0016" class="sec sec-first"><p></p><h4 id="cts13678-sec-0016title" class="inline">Tenofovir </h4><p class="p p-first">The mean observed tenofovir clearance in the study participants was 168.7&#x02009;&#x000b1;&#x02009;101.7&#x02009;mL/min, approximately two&#x02010;times higher than iGFR. The mean predicted tenofovir clearance using the mechanistic PBPK model was 162.8&#x02009;&#x000b1;&#x02009;79.8&#x02009;mL/min. Using linear regression and iGFR as the independent variable, the predicted tenofovir clearance exhibited a mean absolute error of 41.7&#x02009;mL/min (<em>R</em>
<sup>2</sup>&#x02009;=&#x02009;0.57; Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0002" rid-ob="ob-cts13678-fig-0002" co-legend-rid="lgnd_cts13678-fig-0002"><span>2a,c,e</span></a>). Using the mechanistic kidney model trained with individual iGFR, isovalerylglycine derived blood flow, and KA clearance, tenofovir clearance prediction exhibited the lowest mean error point estimate of 37&#x02009;mL/min (<em>R</em>
<sup>2</sup>&#x02009;=&#x02009;0.71; Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0002" rid-ob="ob-cts13678-fig-0002" co-legend-rid="lgnd_cts13678-fig-0002"><span>2b,d,f</span></a>). Using bootstrapping, the mechanistic PBPK model prediction had a mean error of 37.1&#x02009;mL/min (95% CI: 24.0&#x02013;52.9) compared to the iGFR linear regression model which had a mean error of 41.8&#x02009;mL/min (95% CI: 25.0&#x02013;61.6). All individual predictions and observations of tenofovir are summarized in Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0004/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0004" rid-ob="ob-cts13678-tbl-0004" co-legend-rid=""><span>4</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="cts13678-tbl-0004"><h3>TABLE 4</h3><!--caption a7--><div class="caption"><p>Observed versus predicted kidney clearance for TFV and OS for each subject.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">ID</th><th align="left" valign="bottom" rowspan="1" colspan="1">Observed TFV CL<sub>r</sub>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Predicted TFV CL<sub>r</sub>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">P/O ratio of TFV CL<sub>r</sub>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Observed OC CL<sub>r</sub>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Predicted OC CL<sub>r</sub>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">P/O ratio of OC CL<sub>r</sub>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">240</td><td align="center" valign="top" rowspan="1" colspan="1">244</td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td><td align="center" valign="top" rowspan="1" colspan="1">257</td><td align="center" valign="top" rowspan="1" colspan="1">263</td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">197</td><td align="center" valign="top" rowspan="1" colspan="1">233</td><td align="center" valign="top" rowspan="1" colspan="1">1.18</td><td align="center" valign="top" rowspan="1" colspan="1">225</td><td align="center" valign="top" rowspan="1" colspan="1">253</td><td align="center" valign="top" rowspan="1" colspan="1">1.12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">231</td><td align="center" valign="top" rowspan="1" colspan="1">301</td><td align="center" valign="top" rowspan="1" colspan="1">1.30</td><td align="center" valign="top" rowspan="1" colspan="1">230</td><td align="center" valign="top" rowspan="1" colspan="1">328</td><td align="center" valign="top" rowspan="1" colspan="1">1.43</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">236</td><td align="center" valign="top" rowspan="1" colspan="1">154</td><td align="center" valign="top" rowspan="1" colspan="1">0.65</td><td align="center" valign="top" rowspan="1" colspan="1">232</td><td align="center" valign="top" rowspan="1" colspan="1">163</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">1.33</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">1.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">64</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">1.17</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">80</td><td align="center" valign="top" rowspan="1" colspan="1">1.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">87</td><td align="center" valign="top" rowspan="1" colspan="1">102</td><td align="center" valign="top" rowspan="1" colspan="1">1.17</td><td align="center" valign="top" rowspan="1" colspan="1">74</td><td align="center" valign="top" rowspan="1" colspan="1">117</td><td align="center" valign="top" rowspan="1" colspan="1">1.58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">82</td><td align="center" valign="top" rowspan="1" colspan="1">113</td><td align="center" valign="top" rowspan="1" colspan="1">1.38</td><td align="center" valign="top" rowspan="1" colspan="1">115</td><td align="center" valign="top" rowspan="1" colspan="1">122</td><td align="center" valign="top" rowspan="1" colspan="1">1.06</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">111</td><td align="center" valign="top" rowspan="1" colspan="1">123</td><td align="center" valign="top" rowspan="1" colspan="1">1.11</td><td align="center" valign="top" rowspan="1" colspan="1">130</td><td align="center" valign="top" rowspan="1" colspan="1">132</td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">76</td><td align="center" valign="top" rowspan="1" colspan="1">76</td><td align="center" valign="top" rowspan="1" colspan="1">1.00</td><td align="center" valign="top" rowspan="1" colspan="1">102</td><td align="center" valign="top" rowspan="1" colspan="1">81</td><td align="center" valign="top" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">128</td><td align="center" valign="top" rowspan="1" colspan="1">152</td><td align="center" valign="top" rowspan="1" colspan="1">1.19</td><td align="center" valign="top" rowspan="1" colspan="1">94</td><td align="center" valign="top" rowspan="1" colspan="1">163</td><td align="center" valign="top" rowspan="1" colspan="1">1.73</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">179</td><td align="center" valign="top" rowspan="1" colspan="1">158</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td><td align="center" valign="top" rowspan="1" colspan="1">193</td><td align="center" valign="top" rowspan="1" colspan="1">172</td><td align="center" valign="top" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">464</td><td align="center" valign="top" rowspan="1" colspan="1">287</td><td align="center" valign="top" rowspan="1" colspan="1">0.62</td><td align="center" valign="top" rowspan="1" colspan="1">361</td><td align="center" valign="top" rowspan="1" colspan="1">309</td><td align="center" valign="top" rowspan="1" colspan="1">0.86</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">181</td><td align="center" valign="top" rowspan="1" colspan="1">171</td><td align="center" valign="top" rowspan="1" colspan="1">0.94</td><td align="center" valign="top" rowspan="1" colspan="1">205</td><td align="center" valign="top" rowspan="1" colspan="1">184</td><td align="center" valign="top" rowspan="1" colspan="1">0.90</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">116</td><td align="center" valign="top" rowspan="1" colspan="1">153</td><td align="center" valign="top" rowspan="1" colspan="1">1.32</td><td align="center" valign="top" rowspan="1" colspan="1">58</td><td align="center" valign="top" rowspan="1" colspan="1">166</td><td align="center" valign="top" rowspan="1" colspan="1">2.86</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">209</td><td align="center" valign="top" rowspan="1" colspan="1">146</td><td align="center" valign="top" rowspan="1" colspan="1">0.70</td><td align="center" valign="top" rowspan="1" colspan="1">247</td><td align="center" valign="top" rowspan="1" colspan="1">160</td><td align="center" valign="top" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">248</td><td align="center" valign="top" rowspan="1" colspan="1">187</td><td align="center" valign="top" rowspan="1" colspan="1">0.75</td><td align="center" valign="top" rowspan="1" colspan="1">281</td><td align="center" valign="top" rowspan="1" colspan="1">200</td><td align="center" valign="top" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">195</td><td align="center" valign="top" rowspan="1" colspan="1">181</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td><td align="center" valign="top" rowspan="1" colspan="1">308</td><td align="center" valign="top" rowspan="1" colspan="1">198</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">260</td><td align="center" valign="top" rowspan="1" colspan="1">187</td><td align="center" valign="top" rowspan="1" colspan="1">0.72</td><td align="center" valign="top" rowspan="1" colspan="1">297</td><td align="center" valign="top" rowspan="1" colspan="1">201</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">163</td><td align="center" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td><td align="center" valign="top" rowspan="1" colspan="1">167</td><td align="center" valign="top" rowspan="1" colspan="1">153</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">105</td><td align="center" valign="top" rowspan="1" colspan="1">103</td><td align="center" valign="top" rowspan="1" colspan="1">0.98</td><td align="center" valign="top" rowspan="1" colspan="1">112</td><td align="center" valign="top" rowspan="1" colspan="1">125</td><td align="center" valign="top" rowspan="1" colspan="1">1.12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">124</td><td align="center" valign="top" rowspan="1" colspan="1">236</td><td align="center" valign="top" rowspan="1" colspan="1">1.90</td><td align="center" valign="top" rowspan="1" colspan="1">265</td><td align="center" valign="top" rowspan="1" colspan="1">277</td><td align="center" valign="top" rowspan="1" colspan="1">1.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">404</td><td align="center" valign="top" rowspan="1" colspan="1">363</td><td align="center" valign="top" rowspan="1" colspan="1">0.90</td><td align="center" valign="top" rowspan="1" colspan="1">440</td><td align="center" valign="top" rowspan="1" colspan="1">405</td><td align="center" valign="top" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">177</td><td align="center" valign="top" rowspan="1" colspan="1">204</td><td align="center" valign="top" rowspan="1" colspan="1">1.15</td><td align="center" valign="top" rowspan="1" colspan="1">157</td><td align="center" valign="top" rowspan="1" colspan="1">241</td><td align="center" valign="top" rowspan="1" colspan="1">1.54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">174</td><td align="center" valign="top" rowspan="1" colspan="1">1.22</td><td align="center" valign="top" rowspan="1" colspan="1">157</td><td align="center" valign="top" rowspan="1" colspan="1">197</td><td align="center" valign="top" rowspan="1" colspan="1">1.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">0.89</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">39</td><td align="center" valign="top" rowspan="1" colspan="1">1.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">61</td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">0.79</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140404424485072"><a target="object" rel="noopener" href="/pmc/articles/PMC10766039/table/cts13678-tbl-0004/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="cts13678-note-0014"><p class="p p-first-last">Abbreviations: CL<sub>r</sub>, renal clearance; OC, oseltamivir; P/O ratio, prediction&#x02010;over&#x02010;observation ratio of renal drug clearance; TFV, tenofovir.</p></div></div></div></div><div id="cts13678-sec-0017" class="sec sec-last"><p></p><h4 id="cts13678-sec-0017title" class="inline">Oseltamivir carboxylate </h4><p class="p p-first-last">The mean observed oseltamivir clearance carboxylate was 182.8&#x02009;&#x000b1;&#x02009;103.7&#x02009;mL/min, compared to predicted clearance using the mechanistic PBPK model of 178.9&#x02009;&#x000b1;&#x02009;88.5&#x02009;mL/min. Using linear regression and iGFR, the mean absolute error in predicting oseltamivir clearance carboxylate was 48.4&#x02009;mL/min (<em>R</em>
<sup>2</sup>&#x02009;=&#x02009;0.54; Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0003" rid-ob="ob-cts13678-fig-0003" co-legend-rid="lgnd_cts13678-fig-0003"><span>3a,c,e</span></a>). The mechanistic model trained with iGFR, isovalerylglycine derived blood flow, and KA clearance, resulted in the lowest mean absolute error of 42.9&#x02009;mL/min (<em>R</em>
<sup>2</sup>&#x02009;=&#x02009;0.69; Figure&#x000a0;<a href="/pmc/articles/PMC10766039/figure/cts13678-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="cts13678-fig-0003" rid-ob="ob-cts13678-fig-0003" co-legend-rid="lgnd_cts13678-fig-0003"><span>3b,d,f</span></a>). Using bootstrapping, the mean error of the mechanistic PBPK model was 42.9&#x02009;mL/min (95% CI: 29.7&#x02013;56.4), compared to the mean error of 48.1&#x02009;mL/min (95% CI: 31.2&#x02013;67.3) from linear regression. All individual predictions and observations of oseltamivir carboxylate are summarized in Table&#x000a0;<a href="/pmc/articles/PMC10766039/table/cts13678-tbl-0004/" target="table" class="fig-table-link figpopup" rid-figpopup="cts13678-tbl-0004" rid-ob="ob-cts13678-tbl-0004" co-legend-rid=""><span>4</span></a>.</p></div></div></div><div id="cts13678-sec-0018" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0018title">DISCUSSION</h2><p class="p p-first">In this study, we demonstrate the ability to predict the kidney clearance of tenofovir and oseltamivir carboxylate, two drugs with complex kidney elimination pathways, using a physiologically&#x02010;based mechanistic kidney model informed by biomarker&#x02010;based representations of KBF and OAT&#x02010;mediated tubular secretory clearance, as well as GFR, with improved prediction accuracy over regression by GFR. The mechanistic model allows simultaneous consideration of glomerular filtration, passive re&#x02010;absorption, and active secretion with various levels of kidney function; in prior usage the relative changes in glomerular versus tubular hemodynamics were generalized to all patients, and to our knowledge this is the first use of a PBPK to incorporate individualized markers of such characteristics to enhance the prediction of different drugs' kidney clearances. Considering that tenofovir and oseltamivir carboxylate are cleared by both glomerular filtration and tubular secretion, this study highlights the ample potential for PBPK models to refine individualized drug clearance prediction and dosing recommendations by incorporating markers of both functions simultaneously.<sup><a href="#cts13678-bib-0012" rid="cts13678-bib-0012" class=" bibr popnode">
12
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0014" rid="cts13678-bib-0014" class=" bibr popnode">
14
</a></sup> This may have implications for dosing of drugs with complex kidney disposition as well as in clinical scenarios expected to result in disparate alterations between glomerular and tubular dynamics.</p><p>It is important to note the potential benefits and drawbacks of modeling kidney function using biomarkers of limited scope. We expect that elimination of freely filtered drugs would best align with GFR whether by endogenous or exogenous markers, however, GFR may not accurately predict the clearance of a predominantly secreted drug.<sup><a href="#cts13678-bib-0027" rid="cts13678-bib-0027" class=" bibr popnode">
27
</a></sup> Our previously developed assay of multiple endogenously produced metabolites was intended to summarily reflect the action of the proximal tubules, however, each metabolite varies significantly in clearance, affinity for transporters, and protein binding.<sup><a href="#cts13678-bib-0016" rid="cts13678-bib-0016" class=" bibr popnode">
16
</a></sup> Given these inherent differences, each solute likely reflects different aspects of clearance and may therefore best predict clearance of biochemically similar compounds. Specificity to secretory clearance differs between each solute, and we continue to search for more optimal and generalizable markers of secretion.<sup><a href="#cts13678-bib-0028" rid="cts13678-bib-0028" class=" bibr popnode">
28
</a></sup> This study estimated secretory clearance by fitting the model to patient&#x02010;specific KA measurements, a metabolite cleared by OAT1/3; whereas tenofovir and oseltamivir carboxylate are also largely cleared by OAT1/3, more data are needed to understand how it would apply to other drugs. Pharmacogenomic studies reveal that variation at individual transporters can significantly modify drug clearance even at the same gross level of organ function, indicating the need for more specific markers.<sup><a href="#cts13678-bib-0029" rid="cts13678-bib-0029" class=" bibr popnode">
29
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0030" rid="cts13678-bib-0030" class=" bibr popnode">
30
</a></sup> Apart from predicting clearance, some metabolites may approximate the risk for drug&#x02013;drug interactions which could aid medication choice and dosing.<sup><a href="#cts13678-bib-0031" rid="cts13678-bib-0031" class=" bibr popnode">
31
</a></sup> Ideally, incorporating multiple solute measurements of different mechanistic specificity could provide the most universal predictive capacity limited only by laboratory practicality. We therefore expect that combining more inclusive information covering different kidney clearance pathways will perform better in predicting kidney pharmacokinetics for the individual, particularly for medications with complex kidney handling.</p><p>There are several strengths of this study. The PBPK model has been previously validated in a large dataset combining kidney perfusion, glomerular filtration, secretion, and passive re&#x02010;absorption.<sup><a href="#cts13678-bib-0010" rid="cts13678-bib-0010" class=" bibr popnode">
10
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0011" rid="cts13678-bib-0011" class=" bibr popnode">
11
</a></sup> Here, we compared predicted and observed drug clearance in a diverse cohort of 27 patients with different stages of kidney impairment, highlighting model versatility. The measurements of isovalerylglycine and KA have been specifically linked to dysfunction of the proximal tubules in other studies, most recently showing tubulointerstitial fibrosis in proportion to clearance reduction.<sup><a href="#cts13678-bib-0032" rid="cts13678-bib-0032" class=" bibr popnode">
32
</a></sup><sup>, </sup><sup><a href="#cts13678-bib-0033" rid="cts13678-bib-0033" class=" bibr popnode">
33
</a></sup> Several limitations should be noted. Some participants were on stable, pharmacologic doses of routine medications that may impact clearance of study drugs or metabolites. KA serves as a reasonable secretory clearance marker for tenofovir and oseltamivir carboxylate owing to commonalities in OAT1/3 clearance, however, as described above, this many not necessarily apply to drugs not cleared by OAT1/3. It is unknown whether different transporters' activity declines differentially or in parallel in chronic kidney disease, and so may limit the generalizability of KA clearance to all routes of tubular secretory clearance; this could be ameliorated by incorporating other secreted endogenous solutes of different transporter specificity. Measurement of KA and isovalerylglycine clearance requires paired plasma and timed urine sampling which can be cumbersome, subject to imprecision, and may complicate clinical adaptation.<sup><a href="#cts13678-bib-0034" rid="cts13678-bib-0034" class=" bibr popnode">
34
</a></sup> Variation in KA and isovalerylglycine clearance could occur due to metabolite or drug interaction, or changes in extra&#x02010;renal clearance, that would hinder model accuracy. Furthermore, functional estimates that violate the physiological principles underpinning the mechanistic model (such as KA clearance exceeding isovalerylglycine clearance) may be challenging to reconcile.</p><p class="p p-last">In summary, this study highlights the potential for improved accuracy and individual&#x02010;level prediction of drug clearance using a PBPK model informed by markers of KBF, glomerular filtration, and tubular secretion. Glomerular filtration alone may fail to capture the function of the tubules; by co&#x02010;measuring KA and isovalerylglycine clearance, markers of tubular secretory clearance, and KBF, respectively, we have shown the ability to predict the kidney clearance of tenofovir and oseltamivir carboxylate across a cohort of patients with varying degrees of kidney impairment. Co&#x02010;measuring GFR with these secretory markers may be a reasonable strategy for future PBPK models to capture added physiologic information about kidney function and, therefore, with further work, allow for improved and more personalized drug dosing for patient use.</p></div><div id="cts13678-sec-0019" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0019title">AUTHOR CONTRIBUTIONS</h2><p class="p p-first-last">M.L.G. and W.H. wrote the manuscript. All authors designed the research. M.L.G. and W.H. performed the research. All authors analyzed the data. C.K.Y., N.I., and B.K. contributed new analytical tools.</p></div><div id="cts13678-sec-0021" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0021title">FUNDING INFORMATION</h2><p class="p p-first-last">No funding was received for this work.</p></div><div id="cts13678-sec-0022" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0022title">CONFLICT OF INTEREST STATEMENT</h2><p class="p p-first-last">The authors declared no competing interests for this work.</p></div><div id="sec-a.p.i" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec-a.p.ititle">Supporting information</h2><!--/article/body/sec/--><div class="sec suppmat" id="cts13678-supitem-0001"><p>
Appendix S1
</p><div class="sup-box half_rhythm" id="media-a.p.i.b.b"><a href="/pmc/articles/PMC10766039/bin/CTS-17-e13678-s001.docx" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(220K, docx)</sup></div></div></div><div id="cts13678-sec-0020" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-sec-0020title">ACKNOWLEDGMENTS</h2><div class="sec"><p>M.L.G. was supported by grants from the American Society of Nephrology as a Ben J. Lipps Award recipient, as well as a Pilot and Feasibility Award granted by the University of Michigan O'Brien Kidney Translational Core Center (NIDDK P30DK081943). N.I. was supported in part by National Institutes of Health grant P01 DA032507 and UW School of Pharmacy's Milo Gibaldi Endowed Chair. C.K.Y. was supported by National Institutes of Health grant R01 GM121354. W.H. is currently a salaried employee and stockholder of Genentech, Inc./Roche. Genentech, Inc./Roche was not involved in the study design and publication. The authors would like to acknowledge and thank all study participants.</p></div></div><div id="notes-a.o.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.o.ctitle">Notes</h2><p>
<span class="mixed-citation" id="CTS13678-cit-2001">
Granda ML, Huang W, Yeung CK, Isoherranen N, Kestenbaum B. <span class="ref-title">Predicting complex kidney drug handling using a physiologically&#x02010;based pharmacokinetic model informed by biomarker&#x02010;estimated secretory clearance and blood flow</span>. <span class="ref-journal">Clin Transl Sci</span>. 2024;<span class="ref-vol">17</span>:e13678. doi: 10.1111/cts.13678
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10766039/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37921258" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fcts.13678" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Transl+Sci&amp;title=Predicting+complex+kidney+drug+handling+using+a+physiologically&#x02010;based+pharmacokinetic+model+informed+by+biomarker&#x02010;estimated+secretory+clearance+and+blood+flow&amp;volume=17&amp;publication_year=2024&amp;pages=e13678&amp;doi=10.1111/cts.13678&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span>
</p><p class="fn-group"><p class="fn sec" id="cts13678-note-0001">Michael L. Granda and Weize Huang contributed equally to the manuscript as co&#x02010;first authors.</p></p></div><div id="cts13678-bibl-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="cts13678-bibl-0001title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0001">1. <span class="mixed-citation" id="cts13678-cit-0001">
Thomson SC, Blantz RC. <span class="ref-title">Glomerulotubular balance, tubuloglomerular feedback, and salt homeostasis</span>. <span class="ref-journal">J Am Soc Nephrol</span>. 2008;<span class="ref-vol">19</span>:2272&#x02010;2275.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18322161" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=Glomerulotubular+balance,+tubuloglomerular+feedback,+and+salt+homeostasis&amp;volume=19&amp;publication_year=2008&amp;pages=2272-2275&amp;pmid=18322161&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0002">2. <span class="mixed-citation" id="cts13678-cit-0002">
Kurokawa K. <span class="ref-title">Tubuloglomerular feedback: its physiological and pathophysiological significance</span>. <span class="ref-journal">Kidney Int Suppl</span>. 1998;<span class="ref-vol">67</span>:S71&#x02010;S74.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/9736257" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int+Suppl&amp;title=Tubuloglomerular+feedback:+its+physiological+and+pathophysiological+significance&amp;volume=67&amp;publication_year=1998&amp;pages=S71-S74&amp;pmid=9736257&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0003">3. <span class="mixed-citation" id="cts13678-cit-0003">
Vallon V, Thomson SC. <span class="ref-title">The tubular hypothesis of nephron filtration and diabetic kidney disease</span>. <span class="ref-journal">Nat Rev Nephrol</span>. 2020;<span class="ref-vol">16</span>:317&#x02010;336.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7242158/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32152499" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&amp;title=The+tubular+hypothesis+of+nephron+filtration+and+diabetic+kidney+disease&amp;volume=16&amp;publication_year=2020&amp;pages=317-336&amp;pmid=32152499&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0004">4. <span class="mixed-citation" id="cts13678-cit-0004">
Han YF, Fan XH, Wang XJ, et&#x000a0;al. <span class="ref-title">Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlorothiazide</span>. <span class="ref-journal">Am J Hypertens</span>. 2011;<span class="ref-vol">24</span>:340&#x02010;346.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/21164499" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=Association+of+intergenic+polymorphism+of+organic+anion+transporter+1+and+3+genes+with+hypertension+and+blood+pressure+response+to+hydrochlorothiazide&amp;volume=24&amp;publication_year=2011&amp;pages=340-346&amp;pmid=21164499&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0005">5. <span class="mixed-citation" id="cts13678-cit-0005">
Matzke GR, Aronoff GR, Atkinson AJ, et&#x000a0;al. <span class="ref-title">Drug dosing consideration in patients with acute and chronic kidney disease&#x02014;a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)</span>. <span class="ref-journal">Kidney Int</span>. 2011;<span class="ref-vol">80</span>:1122&#x02010;1137.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/21918498" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Drug+dosing+consideration+in+patients+with+acute+and+chronic+kidney+disease&#x02014;a+clinical+update+from+Kidney+Disease:+Improving+Global+Outcomes+(KDIGO)&amp;volume=80&amp;publication_year=2011&amp;pages=1122-1137&amp;pmid=21918498&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0006">6. <span class="mixed-citation" id="cts13678-cit-0006">
Lowenstein J, Grantham JJ. <span class="ref-title">The rebirth of interest in renal tubular function</span>. <span class="ref-journal">Am J Physiol Renal Physiol</span>. 2016;<span class="ref-vol">310</span>:F1351&#x02010;F1355.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/26936872" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Renal+Physiol&amp;title=The+rebirth+of+interest+in+renal+tubular+function&amp;volume=310&amp;publication_year=2016&amp;pages=F1351-F1355&amp;pmid=26936872&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0007">7. <span class="mixed-citation" id="cts13678-cit-0007">
Ruiz S, Minville V, Asehnoune K, et&#x000a0;al. <span class="ref-title">Screening of patients with augmented renal clearance in ICU: taking into account the CKD&#x02010;EPI equation, the age, and the cause of admission</span>. <span class="ref-journal">Ann Intensive Care</span>. 2015;<span class="ref-vol">5</span>:49.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4681181/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26667819" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intensive+Care&amp;title=Screening+of+patients+with+augmented+renal+clearance+in+ICU:+taking+into+account+the+CKD&#x02010;EPI+equation,+the+age,+and+the+cause+of+admission&amp;volume=5&amp;publication_year=2015&amp;pages=49&amp;pmid=26667819&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0008">8. <span class="mixed-citation" id="cts13678-cit-0008">
Udy AA, Jarrett P, Stuart J, et&#x000a0;al. <span class="ref-title">Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds</span>. <span class="ref-journal">Crit Care</span>. 2014;<span class="ref-vol">18</span>:657.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4271452/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25432141" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care&amp;title=Determining+the+mechanisms+underlying+augmented+renal+drug+clearance+in+the+critically+ill:+use+of+exogenous+marker+compounds&amp;volume=18&amp;publication_year=2014&amp;pages=657&amp;pmid=25432141&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0009">9. <span class="mixed-citation" id="cts13678-cit-0009">
Perazella MA. <span class="ref-title">Drug use and nephrotoxicity in the intensive care unit</span>. <span class="ref-journal">Kidney Int</span>. 2012;<span class="ref-vol">81</span>:1172&#x02010;1178.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/21124300" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Drug+use+and+nephrotoxicity+in+the+intensive+care+unit&amp;volume=81&amp;publication_year=2012&amp;pages=1172-1178&amp;pmid=21124300&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0010">10. <span class="mixed-citation" id="cts13678-cit-0010">
Huang W, Isoherranen N. <span class="ref-title">Novel mechanistic PBPK model to predict renal clearance in varying stages of CKD by incorporating tubular adaptation and dynamic passive reabsorption</span>. <span class="ref-journal">CPT Pharmacometrics Syst Pharmacol</span>. 2020;<span class="ref-vol">9</span>:571&#x02010;583.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7577018/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32977369" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CPT+Pharmacometrics+Syst+Pharmacol&amp;title=Novel+mechanistic+PBPK+model+to+predict+renal+clearance+in+varying+stages+of+CKD+by+incorporating+tubular+adaptation+and+dynamic+passive+reabsorption&amp;volume=9&amp;publication_year=2020&amp;pages=571-583&amp;pmid=32977369&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0011">11. <span class="mixed-citation" id="cts13678-cit-0011">
Huang W, Isoherranen N. <span class="ref-title">Development of a dynamic physiologically based mechanistic kidney model to predict renal clearance</span>. <span class="ref-journal">CPT Pharmacometrics Syst Pharmacol</span>. 2018;<span class="ref-vol">7</span>:593&#x02010;602.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6157663/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30043446" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CPT+Pharmacometrics+Syst+Pharmacol&amp;title=Development+of+a+dynamic+physiologically+based+mechanistic+kidney+model+to+predict+renal+clearance&amp;volume=7&amp;publication_year=2018&amp;pages=593-602&amp;pmid=30043446&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0012">12. <span class="mixed-citation" id="cts13678-cit-0012">
Calcagno A, Cusato J, Marinaro L, et&#x000a0;al. <span class="ref-title">Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines</span>. <span class="ref-journal">Pharmacogenomics J</span>. 2016;<span class="ref-vol">16</span>:514&#x02010;518.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/26440731" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics+J&amp;title=Clinical+pharmacology+of+tenofovir+clearance:+a+pharmacokinetic/pharmacogenetic+study+on+plasma+and+urines&amp;volume=16&amp;publication_year=2016&amp;pages=514-518&amp;pmid=26440731&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0013">13. <span class="mixed-citation" id="cts13678-cit-0013">
Kohler JJ, Hosseini SH, Green E, et&#x000a0;al. <span class="ref-title">Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters</span>. <span class="ref-journal">Lab Investig J Tech Methods Pathol</span>. 2011;<span class="ref-vol">91</span>:852&#x02010;858. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3103636/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21403643" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lab+Investig+J+Tech+Methods+Pathol&amp;title=Tenofovir+renal+proximal+tubular+toxicity+is+regulated+by+OAT1+and+MRP4+transporters&amp;volume=91&amp;publication_year=2011&amp;pages=852-858&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0014">14. <span class="mixed-citation" id="cts13678-cit-0014">
He G, Massarella J, Ward P. <span class="ref-title">Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64&#x02010;0802</span>. <span class="ref-journal">Clin Pharmacokinet</span>. 1999;<span class="ref-vol">37</span>:471&#x02010;484.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/10628898" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacokinet&amp;title=Clinical+pharmacokinetics+of+the+prodrug+oseltamivir+and+its+active+metabolite+Ro+64&#x02010;0802&amp;volume=37&amp;publication_year=1999&amp;pages=471-484&amp;pmid=10628898&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0015">15. <span class="mixed-citation" id="cts13678-cit-0015">
Hill G, Cihlar T, Oo C, et&#x000a0;al. <span class="ref-title">The anti&#x02010;influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion&#x02014;correlation of in&#x000a0;vivo and in&#x000a0;vitro studies</span>. <span class="ref-journal">Drug Metab Dispos</span>. 2002;<span class="ref-vol">30</span>:13&#x02010;19.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/11744606" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos&amp;title=The+anti&#x02010;influenza+drug+oseltamivir+exhibits+low+potential+to+induce+pharmacokinetic+drug+interactions+via+renal+secretion&#x02014;correlation+of+in&#x000a0;vivo+and+in&#x000a0;vitro+studies&amp;volume=30&amp;publication_year=2002&amp;pages=13-19&amp;pmid=11744606&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0016">16. <span class="mixed-citation" id="cts13678-cit-0016">
Chen Y, Zelnick LR, Hoofnagle AN, et&#x000a0;al. <span class="ref-title">Prediction of kidney drug clearance: a comparison of tubular secretory clearance and glomerular filtration rate</span>. <span class="ref-journal">J Am Soc Nephrol</span>. 2021;<span class="ref-vol">32</span>:459&#x02010;468.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8054886/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33239392" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=Prediction+of+kidney+drug+clearance:+a+comparison+of+tubular+secretory+clearance+and+glomerular+filtration+rate&amp;volume=32&amp;publication_year=2021&amp;pages=459-468&amp;pmid=33239392&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0017">17. <span class="mixed-citation" id="cts13678-cit-0017">
Chen Y, Zelnick LR, Wang K, et&#x000a0;al. <span class="ref-title">CRIC Study Investigators: association of tubular solute clearances with the glomerular filtration rate and complications of chronic kidney disease: the chronic renal insufficiency cohort study</span>. <span class="ref-journal">Nephrol Dial Transplant</span>. 2020;<span class="ref-vol">36</span>:1271&#x02010;1281.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8237987/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33330914" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol+Dial+Transplant&amp;title=CRIC+Study+Investigators:+association+of+tubular+solute+clearances+with+the+glomerular+filtration+rate+and+complications+of+chronic+kidney+disease:+the+chronic+renal+insufficiency+cohort+study&amp;volume=36&amp;publication_year=2020&amp;pages=1271-1281&amp;pmid=33330914&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0018">18. <span class="mixed-citation" id="cts13678-cit-0018">
Mor A, Kalaska B, Pawlak D. <span class="ref-title">Kynurenine pathway in chronic kidney disease: what's old, what's new, and what's next?</span>
<span class="ref-journal">Int J Tryptophan Res</span>. 2020;<span class="ref-vol">13</span>:1178646920954882.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8862190/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35210786" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Tryptophan+Res&amp;title=Kynurenine+pathway+in+chronic+kidney+disease:+what's+old,+what's+new,+and+what's+next?&amp;volume=13&amp;publication_year=2020&amp;pages=1178646920954882&amp;pmid=35210786&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0019">19. <span class="mixed-citation" id="cts13678-cit-0019">
Uwai Y, Honjo H, Iwamoto K. <span class="ref-title">Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3</span>. <span class="ref-journal">Pharmacol Res</span>. 2012;<span class="ref-vol">65</span>:254&#x02010;260.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/22108572" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Res&amp;title=Interaction+and+transport+of+kynurenic+acid+via+human+organic+anion+transporters+hOAT1+and+hOAT3&amp;volume=65&amp;publication_year=2012&amp;pages=254-260&amp;pmid=22108572&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0020">20. <span class="mixed-citation" id="cts13678-cit-0020">
Delanaye P, Ebert N, Melsom T, et&#x000a0;al. <span class="ref-title">Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: how to measure glomerular filtration rate with iohexol?</span>
<span class="ref-journal">Clin Kidney J</span>. 2016;<span class="ref-vol">9</span>:682&#x02010;699.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5036902/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27679715" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Kidney+J&amp;title=Iohexol+plasma+clearance+for+measuring+glomerular+filtration+rate+in+clinical+practice+and+research:+a+review.+Part+1:+how+to+measure+glomerular+filtration+rate+with+iohexol?&amp;volume=9&amp;publication_year=2016&amp;pages=682-699&amp;pmid=27679715&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0021">21. <span class="mixed-citation" id="cts13678-cit-0021">
Huang W, Czuba LC, Isoherranen N. <span class="ref-title">Mechanistic PBPK modeling of urine pH effect on renal and systemic disposition of methamphetamine and amphetamine</span>. <span class="ref-journal">J Pharmacol Exp Ther</span>. 2020;<span class="ref-vol">373</span>:488&#x02010;501.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7250368/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32198137" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharmacol+Exp+Ther&amp;title=Mechanistic+PBPK+modeling+of+urine+pH+effect+on+renal+and+systemic+disposition+of+methamphetamine+and+amphetamine&amp;volume=373&amp;publication_year=2020&amp;pages=488-501&amp;pmid=32198137&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0022">22. <span class="mixed-citation" id="cts13678-cit-0022">
Jansen J, Jankowski J, Gajjala PR, Wetzels JFM, Masereeuw R. <span class="ref-title">Disposition and clinical implications of protein&#x02010;bound uremic toxins</span>. <span class="ref-journal">Clin Sci</span>. 2017;<span class="ref-vol">131</span>:1631&#x02010;1647. [<a href="https://pubmed.ncbi.nlm.nih.gov/28667064" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Sci&amp;title=Disposition+and+clinical+implications+of+protein&#x02010;bound+uremic+toxins&amp;volume=131&amp;publication_year=2017&amp;pages=1631-1647&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0023">23. <span class="mixed-citation" id="cts13678-cit-0023">
Ma Y, Xin M, Li K, et&#x000a0;al. <span class="ref-title">An LC&#x02010;MS/MS analytical method for the determination of uremic toxins in patients with end&#x02010;stage renal disease</span>. <span class="ref-journal">J Pharm Biomed Anal</span>. 2020;<span class="ref-vol">191</span>:113551.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/32889350" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pharm+Biomed+Anal&amp;title=An+LC&#x02010;MS/MS+analytical+method+for+the+determination+of+uremic+toxins+in+patients+with+end&#x02010;stage+renal+disease&amp;volume=191&amp;publication_year=2020&amp;pages=113551&amp;pmid=32889350&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0024">24. <span class="mixed-citation" id="cts13678-cit-0024">
Kumar R, Adiga A, Novack J, et&#x000a0;al. <span class="ref-title">The renal transport of hippurate and protein&#x02010;bound solutes</span>. <span class="ref-journal">Physiol Rep</span>. 2020;<span class="ref-vol">8</span>:e14349.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7041931/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32097533" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Rep&amp;title=The+renal+transport+of+hippurate+and+protein&#x02010;bound+solutes&amp;volume=8&amp;publication_year=2020&amp;pages=e14349&amp;pmid=32097533&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0025">25. <span class="mixed-citation" id="cts13678-cit-0025">
<span class="ref-title">Drugs@FDA: FDA&#x02010;Approved Drugs</span>. <a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process%26ApplNo=021752" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&#x00026;ApplNo=021752</a>. Accessed April 19, 2022.</span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0026">26. <span class="mixed-citation" id="cts13678-cit-0026">
<span class="ref-title">Drugs@FDA: FDA&#x02010;Approved Drugs</span>. <a href="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process%26applno=021087" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&#x00026;applno=021087</a>. Accessed April 19, 2022.</span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0027">27. <span class="mixed-citation" id="cts13678-cit-0027">
Hall AM, Trepiccione F, Unwin RJ. <span class="ref-title">Drug toxicity in the proximal tubule: new models, methods and mechanisms</span>. <span class="ref-journal">Pediatr Nephrol</span>. 2022;<span class="ref-vol">37</span>:973&#x02010;982.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9023418/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34050397" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Nephrol&amp;title=Drug+toxicity+in+the+proximal+tubule:+new+models,+methods+and+mechanisms&amp;volume=37&amp;publication_year=2022&amp;pages=973-982&amp;pmid=34050397&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0028">28. <span class="mixed-citation" id="cts13678-cit-0028">
Granda ML, Prince DK, Fiehn O, et&#x000a0;al. <span class="ref-title">Metabolomic profiling identifies new endogenous markers of tubular secretory clearance</span>. <span class="ref-journal">Kidney360</span>. 2022;<span class="ref-vol">4</span>(<span class="ref-iss">1</span>):23&#x02010;31. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10101621/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36700901" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney360&amp;title=Metabolomic+profiling+identifies+new+endogenous+markers+of+tubular+secretory+clearance&amp;volume=4&amp;issue=1&amp;publication_year=2022&amp;pages=23-31&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0029">29. <span class="mixed-citation" id="cts13678-cit-0029">
Evans WE, McLeod HL. <span class="ref-title">Pharmacogenomics &#x02014; drug disposition, drug targets, and side effects</span>. <span class="ref-journal">N Engl J Med</span>. 2003;<span class="ref-vol">348</span>:538&#x02010;549.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/12571262" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Pharmacogenomics+&#x02014;+drug+disposition,+drug+targets,+and+side+effects&amp;volume=348&amp;publication_year=2003&amp;pages=538-549&amp;pmid=12571262&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0030">30. <span class="mixed-citation" id="cts13678-cit-0030">
Taube SE, Clark GM, Dancey JE, McShane LM, Sigman CC, Gutman SI. <span class="ref-title">A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment</span>. <span class="ref-journal">J Natl Cancer Inst</span>. 2009;<span class="ref-vol">101</span>:1453&#x02010;1463.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2773185/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19855077" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Natl+Cancer+Inst&amp;title=A+perspective+on+challenges+and+issues+in+biomarker+development+and+drug+and+biomarker+codevelopment&amp;volume=101&amp;publication_year=2009&amp;pages=1453-1463&amp;pmid=19855077&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0031">31. <span class="mixed-citation" id="cts13678-cit-0031">
Tang J, Shen H, Zhao X, et&#x000a0;al. <span class="ref-title">Endogenous plasma kynurenic acid in human: a newly discovered biomarker for drug&#x02010;drug interactions involving organic anion transporter 1 and 3 inhibition</span>. <span class="ref-journal">Drug Metab Dispos Biol Fate Chem</span>. 2021;<span class="ref-vol">49</span>:1063&#x02010;1069.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/34599018" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos+Biol+Fate+Chem&amp;title=Endogenous+plasma+kynurenic+acid+in+human:+a+newly+discovered+biomarker+for+drug&#x02010;drug+interactions+involving+organic+anion+transporter+1+and+3+inhibition&amp;volume=49&amp;publication_year=2021&amp;pages=1063-1069&amp;pmid=34599018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0032">32. <span class="mixed-citation" id="cts13678-cit-0032">
Granda ML, Zelnick LR, Prince DK, Hoofnagle A, Young BA, Kestenbaum B. <span class="ref-title">Tubular secretion and eGFR decline in the Jackson Heart Study</span>. <span class="ref-journal">Kidney Int Rep</span>. 2022;<span class="ref-vol">7</span>(<span class="ref-iss">12</span>):2668&#x02010;2675.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9727527/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36506244" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int+Rep&amp;title=Tubular+secretion+and+eGFR+decline+in+the+Jackson+Heart+Study&amp;volume=7&amp;issue=12&amp;publication_year=2022&amp;pages=2668-2675&amp;pmid=36506244&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0033">33. <span class="mixed-citation" id="cts13678-cit-0033">
Garimella PS, Katz R, Waikar SS, et&#x000a0;al. <span class="ref-title">Kidney tubulointerstitial fibrosis and tubular secretion</span>. <span class="ref-journal">Am J Kidney Dis</span>. 2022;<span class="ref-vol">79</span>:709&#x02010;716.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8973399/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34571064" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Kidney+Dis&amp;title=Kidney+tubulointerstitial+fibrosis+and+tubular+secretion&amp;volume=79&amp;publication_year=2022&amp;pages=709-716&amp;pmid=34571064&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0034">34. <span class="mixed-citation" id="cts13678-cit-0034">
Kestenbaum B, Ix JH, Gansevoort R, et&#x000a0;al. <span class="ref-title">Population&#x02010;based limits of urine creatinine excretion</span>. <span class="ref-journal">Kidney Int Rep</span>. 2022;<span class="ref-vol">7</span>(<span class="ref-iss">11</span>):2474&#x02010;2483.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9751685/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36531868" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int+Rep&amp;title=Population&#x02010;based+limits+of+urine+creatinine+excretion&amp;volume=7&amp;issue=11&amp;publication_year=2022&amp;pages=2474-2483&amp;pmid=36531868&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0035">35. <span class="mixed-citation" id="cts13678-cit-0035">
Chang S&#x02010;Y, Huang W, Chapron A, et&#x000a0;al. <span class="ref-title">Incorporating uremic solute&#x02010;mediated inhibition of OAT1/3 improves PBPK prediction of tenofovir renal and systemic disposition in patients with severe kidney disease</span>. <span class="ref-journal">Pharm Res</span>. 2023. 10.1007/s11095-023-03594-x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/37704895" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs11095-023-03594-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharm+Res&amp;title=Incorporating+uremic+solute&#x02010;mediated+inhibition+of+OAT1/3+improves+PBPK+prediction+of+tenofovir+renal+and+systemic+disposition+in+patients+with+severe+kidney+disease&amp;publication_year=2023&amp;doi=10.1007/s11095-023-03594-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0036">36. <span class="mixed-citation" id="cts13678-cit-0036">
Instiaty I, Lindegardh N, Jittmala P, et&#x000a0;al. <span class="ref-title">Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers</span>. <span class="ref-journal">Antimicrob Agents Chemother</span>. 2013;<span class="ref-vol">57</span>:2858&#x02010;2862.
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3716162/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23507284" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antimicrob+Agents+Chemother&amp;title=Comparison+of+oseltamivir+and+oseltamivir+carboxylate+concentrations+in+venous+plasma,+venous+blood,+and+capillary+blood+in+healthy+volunteers&amp;volume=57&amp;publication_year=2013&amp;pages=2858-2862&amp;pmid=23507284&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="cts13678-bib-0037">37. <span class="mixed-citation" id="cts13678-cit-0037">
Morimoto K, Nakakariya M, Shirasaka Y, et&#x000a0;al. <span class="ref-title">Oseltamivir (Tamiflu) efflux transport at the blood&#x02010;brain barrier via P&#x02010;glycoprotein</span>. <span class="ref-journal">Drug Metab Dispos Biol Fate Chem</span>. 2008;<span class="ref-vol">36</span>:6&#x02010;9.
 [<a href="https://pubmed.ncbi.nlm.nih.gov/17940134" ref="reftype=pubmed&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos+Biol+Fate+Chem&amp;title=Oseltamivir+(Tamiflu)+efflux+transport+at+the+blood&#x02010;brain+barrier+via+P&#x02010;glycoprotein&amp;volume=36&amp;publication_year=2008&amp;pages=6-9&amp;pmid=17940134&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10766039&amp;issue-id=452503&amp;journal-id=2996&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Clinical and Translational Science</span> are provided here courtesy of <strong>Wiley</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10766039/pdf/CTS-17-e13678.pdf" class="int-view">PDF (863K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10766039/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10766039/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10766039" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10766039%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="JfP3GROViBTVcmeME87Xdpxj01xvKYculhcrFiQQTC3W7uqdyu2bkOcF59hNPheg">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10766039%2F&amp;text=Predicting%20complex%20kidney%20drug%20handling%20using%20a%20physiologically%02010based%20pharmacokinetic%20model%20informed%20by%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10766039%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766039/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10766039/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37921258/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10766039/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37921258/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10766039/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10766039/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10766039/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
